Immune checkpoint inhibitors for the treatment of MSI-H/MMR-D colorectal cancer and a perspective on resistance mechanisms

IH Sahin, M Akce, O Alese, W Shaib… - British journal of …, 2019 - nature.com
Metastatic colorectal cancer (CRC) with a mismatch repair-deficiency (MMR-
D)/microsatellite instability-high (MSI-H) phenotype carries unique characteristics such as …

The immune contexture in human tumours: impact on clinical outcome

WH Fridman, F Pagès, C Sautès-Fridman… - Nature Reviews …, 2012 - nature.com
Tumours grow within an intricate network of epithelial cells, vascular and lymphatic vessels,
cytokines and chemokines, and infiltrating immune cells. Different types of infiltrating …

Immune infiltration in human tumors: a prognostic factor that should not be ignored

J Galon, MC Dieu-Nosjean, E Tartour… - Oncogene, 2010 - nature.com
The natural history of a tumor includes phases of 'in situ'growth, invasion, extravasation and
metastasis. During these phases, tumor cells interact with their microenvironment and are …

The immune biology of microsatellite-unstable cancer

M Kloor, M von Knebel Doeberitz - Trends in cancer, 2016 - cell.com
Deficient DNA mismatch repair (MMR) boosts the accumulation of frameshift mutations in
genes encompassing coding microsatellites (cMS). This results in the translation of proteins …

Tumour‐infiltrating T‐cell subsets, molecular changes in colorectal cancer, and prognosis: cohort study and literature review

K Nosho, Y Baba, N Tanaka, K Shima… - The Journal of …, 2010 - Wiley Online Library
The abundance of tumour‐infiltrating T‐cells has been associated with microsatellite
instability (MSI) and a favourable prognosis in colorectal cancer. However, numerous …

Tumor-associated macrophages and regulatory T cells infiltration and the clinical outcome in colorectal cancer

D Waniczek, Z Lorenc, M Śnietura, M Wesecki… - Archivum immunologiae …, 2017 - Springer
The aim of the study is the assessment of the intensity of the infiltration of tumor-associated
macrophages (TAMs) CD68+/iNOS− and Tregs CD8+/FoxP3+ in colorectal cancer (CRC) …

High frequency of tumor‐infiltrating FOXP3+ regulatory T cells predicts improved survival in mismatch repair‐proficient colorectal cancer patients

DM Frey, RA Droeser, CT Viehl, I Zlobec… - … journal of cancer, 2010 - Wiley Online Library
Regulatory T cells (Treg) inhibit the generation of host‐versus‐tumor immunity via
suppression of tumor‐specific effector T‐cell responses and development of immune …

Cancer immunology—analysis of host and tumor factors for personalized medicine

S Ogino, J Galon, CS Fuchs, G Dranoff - Nature reviews Clinical …, 2011 - nature.com
Immune cells in the tumor microenvironment have an important role in regulating tumor
progression. Therefore, stimulating immune reactions to tumors can be an attractive …

Rational bases for the use of the Immunoscore in routine clinical settings as a prognostic and predictive biomarker in cancer patients

A Kirilovsky, F Marliot, C El Sissy… - International …, 2016 - academic.oup.com
Abstract The American Joint Committee on Cancer/Union Internationale Contre le Cancer
(AJCC/UICC) tumor, nodes, metastasis (TNM) classification system based on tumor features …

Physical plasma-treated saline promotes an immunogenic phenotype in CT26 colon cancer cells in vitro and in vivo

E Freund, KR Liedtke, J van der Linde… - Scientific reports, 2019 - nature.com
Metastatic colorectal cancer is the fourth most common cause of cancer death. Current
options in palliation such as hyperthermic intraperitoneal chemotherapy (HIPEC) present …